The historical rank and industry rank for Akebia Therapeutics's Days Inventory or its related term are showing as below:
AKBA'
s Days Inventory Range Over the Past 10 Years
Min: 91.7 Med: 121.2 Max: 5368.1
Current: 96.62
During the past 12 years, Akebia Therapeutics's highest Days Inventory was 5368.10. The lowest was 91.70. And the median was 121.20.
AKBA's Days Inventory is ranked better than 76.12% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs AKBA: 96.62
Akebia Therapeutics's Days Inventory
increased
from Dec. 2022 (0.00) to Dec. 2023 (83.44).
It might indicate that Akebia Therapeutics's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Akebia Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 was 1.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Akebia Therapeutics's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.30.
Akebia Therapeutics Days Inventory Historical Data
The historical data trend for Akebia Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Akebia Therapeutics's Days Inventory
For the Biotechnology subindustry, Akebia Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akebia Therapeutics's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Akebia Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Akebia Therapeutics's Days Inventory falls into.
Akebia Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Akebia Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akebia Therapeutics (NAS:AKBA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Akebia Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Akebia Therapeutics's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Akebia Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of Akebia Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Akebia Therapeutics (Akebia Therapeutics) Business Description
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes 1) Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease. 2) Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients. 3) HIF-PH inhibitors in preclinical development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AKBA has been successfully added to your 